Adverse events should be reported. Reporting forms and information can be found at: https://yellowcard.mhra.gov.uk, or search for MHRA Yellow Card in the Google Play or Apple App Store.

Adverse events should also be reported to Ferndale Pharmaceuticals Ltd on 01937 541122

The medicinal company products are manufactured and released by pharmaceutical GMP certified facilities and it distributes its products to pharmaceutical GDP operating under WDA Number: 20685

FERNDALE PHARMA

The divisions medicinal products are approved by the MHRA to be used by healthcare providers and patients to improve health and quality of life improvements for the following conditions:

Skin pain associated with venous cannulation, venepuncture, and painful treatments on larger areas of skin

By providing surface anaesthesia,

  • LMX4 4% w/w Cream.

Click here to access the summary of product characteristics and product information leaflet.
Classification: Pharmacy medicine.

Rosacea

By treating acute inflammatory episodes

  • Acea 0.75% w/w Gel

Click here to access the summary of product characteristics and product information leaflet.
Classification: Prescription only medicine.

Spider, reticular and varicose leg veins

By providing sclerotherapy treatment

Click to access the summary of product characteristics and product information leaflet.

Classification: Prescription only medicine. Supplied in partnership with Kreussler Pharma.